CN113621461A - 一种通络降糖护肝酒及其制备方法 - Google Patents
一种通络降糖护肝酒及其制备方法 Download PDFInfo
- Publication number
- CN113621461A CN113621461A CN202111058662.0A CN202111058662A CN113621461A CN 113621461 A CN113621461 A CN 113621461A CN 202111058662 A CN202111058662 A CN 202111058662A CN 113621461 A CN113621461 A CN 113621461A
- Authority
- CN
- China
- Prior art keywords
- parts
- liver
- water
- wine
- dredging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 55
- 239000008280 blood Substances 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 240000004922 Vigna radiata Species 0.000 claims abstract description 28
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 28
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 240000006162 Chenopodium quinoa Species 0.000 claims abstract description 23
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 18
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims abstract description 13
- 240000008892 Helianthus tuberosus Species 0.000 claims abstract description 13
- 235000003230 Helianthus tuberosus Nutrition 0.000 claims abstract description 13
- 244000280244 Luffa acutangula Species 0.000 claims abstract description 13
- 235000009814 Luffa aegyptiaca Nutrition 0.000 claims abstract description 13
- 241000352057 Solanum vernei Species 0.000 claims abstract description 13
- 235000004976 Solanum vernei Nutrition 0.000 claims abstract description 13
- 102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 13
- 108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 13
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002304 perfume Substances 0.000 claims abstract description 13
- 239000010902 straw Substances 0.000 claims abstract description 13
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 8
- 241000235342 Saccharomycetes Species 0.000 claims abstract description 7
- 244000241257 Cucumis melo Species 0.000 claims abstract 4
- 238000009835 boiling Methods 0.000 claims description 30
- 238000000855 fermentation Methods 0.000 claims description 18
- 230000004151 fermentation Effects 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 210000004185 liver Anatomy 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000001816 cooling Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 238000010025 steaming Methods 0.000 claims description 11
- 229920000742 Cotton Polymers 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 239000003651 drinking water Substances 0.000 claims description 7
- 235000020188 drinking water Nutrition 0.000 claims description 7
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 5
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 5
- 244000276331 Citrus maxima Species 0.000 claims description 5
- 235000001759 Citrus maxima Nutrition 0.000 claims description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 150000007513 acids Chemical class 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 5
- 235000008434 ginseng Nutrition 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 235000013599 spices Nutrition 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 241000190633 Cordyceps Species 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 7
- 239000008103 glucose Substances 0.000 abstract description 7
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 3
- 208000006820 Arthralgia Diseases 0.000 abstract description 2
- 208000000112 Myalgia Diseases 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 230000002929 anti-fatigue Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 description 17
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000010706 fatty liver disease Diseases 0.000 description 12
- 208000004930 Fatty Liver Diseases 0.000 description 10
- 206010019708 Hepatic steatosis Diseases 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- 231100000240 steatosis hepatitis Toxicity 0.000 description 10
- 241000219112 Cucumis Species 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000005686 eating Nutrition 0.000 description 5
- 235000021251 pulses Nutrition 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 208000007082 Alcoholic Fatty Liver Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010016262 Fatty liver alcoholic Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 208000026594 alcoholic fatty liver disease Diseases 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 206010042727 Swollen tongue Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015210 hypertensive heart disease Diseases 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 235000005955 light diet Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229960004329 metformin hydrochloride Drugs 0.000 description 1
- OETHQSJEHLVLGH-UHFFFAOYSA-N metformin hydrochloride Chemical compound Cl.CN(C)C(=N)N=C(N)N OETHQSJEHLVLGH-UHFFFAOYSA-N 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin hydrochloride Natural products CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/02—Preparation of other alcoholic beverages by fermentation
- C12G3/023—Preparation of other alcoholic beverages by fermentation of botanical family Solanaceae, e.g. potato
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/02—Preparation of other alcoholic beverages by fermentation
- C12G3/026—Preparation of other alcoholic beverages by fermentation with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides, added before or during the fermentation stage; with flavouring ingredients added before or during the fermentation stage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Abstract
本发明公开了一种通络降糖护肝酒，由以下重量份原料组分：鲜紫土豆45‑55份、洋姜3‑10份、虫草参3‑10份、绿豆3‑10份、藜麦3‑10份、新鲜干丝瓜藤秸秆10‑20份、丝瓜络1‑5份、酒曲0.5‑2份、SOD超氧化物歧化酶0.0005‑0.002份、酵母菌0.001‑0.010份、香料水10‑20份。本发明的有益效果为：本发明没有毒副作用，避免对人体健康产生影响；具备抗疲劳功效；能治祛风除湿，舒筋活络；用于筋骨疼痛。可以控制尿糖，酸碱平衡，有降低血压的功效。性温和，无副作用，可长期服用。工艺简单，省工、省时、省力、省钱，比传统酿酒产量增产10—12％出酒率。
Description
技术领域
本发明涉及一种酒，特别涉及一种通络降糖护肝酒及其制备方法。
背景技术
随着人们生活水平的提高以及现在紧张的生活节奏，导致人们的身体处于亚健康状态；糖尿病、脂肪肝、高血压成为现代社会主要流行病； 据最新的《中国成人糖尿病流行与控制现状》调查研究显示，中国18岁及以上成人糖尿病患病率已高达11.6%，糖尿病前期的患病率更是达到了惊人的50.1%.这意味着，每10位中国成年人中，就有6位血糖不正常。脂肪肝在中国人群中的总患病率约10%。脂肪肝有可能会引起血糖升高。脂肪肝是属于一种肝脏的疾病，和脂肪代谢紊乱有关系，可能和平时经常的吃胆固醇、脂肪含量高的食物、缺乏运动等有关。大多数患有脂肪肝的病人身体都比较肥胖，如果不能够控制饮食，控制脂肪肝的发展，是有可能导致血糖升高或者诱发糖尿病的。风湿病是一组侵犯关节、骨骼、肌肉、血管及有关软组织或结缔组织为主的疾病，其中多数为自身免疫性疾病。发病多较隐蔽而缓慢，病程较长，且大多具有遗传倾向。给人们带来极大的痛苦。
发明内容
为解决上述问题，本发明提供了一种通络降糖护肝酒及其制备方法。
一种通络降糖护肝酒，由以下重量份原料组分：鲜紫土豆45-55份、洋姜3-10份、虫草参3-10份、绿豆3-10份、藜麦3-10份、新鲜干丝瓜藤秸秆10-20份、丝瓜络1-5份、酒曲0.5-2份、SOD超氧化物歧化酶0.0005-0.002份、酵母菌0.001-0.010份、香料水10-20份。
优先的由以下重量份原料组分：鲜紫土豆50份、洋姜5份、虫草参5份、绿豆5份、藜麦5份、新鲜干丝瓜藤秸秆15份、丝瓜络2份、酒曲1份、SOD超氧化物歧化酶0.001份、酵母菌0.005份、香料水15份。
所述的香料水包括化橘红、干菊花、水；所述的添加比例为0.5 -1：0.5-1：100-150。
步骤一：将熟鲜紫土豆，洋姜、虫草参洗净，沥干水分，切成1.8-2.2厘米厚的片，上容器蒸18-23分钟；
步骤二：将颗粒饱满、无霉烂的绿豆、藜麦用清水淘洗干净，把饮用水用容器加温38度把淘洗好的绿豆，黎麦浸泡23-25小时后，煮锅加入60%水倒入泡好绿豆，黎麦煮10-20分钟绿豆煮开花，捞出备用；
步骤三：将步骤一、步骤二所得物混合后放入容器中破碎为泥状；充分搅拌混合均匀；
步骤四：将步骤三所得物质加入无霉烂、变质、干叶的破碎至2-3mm的新鲜干丝瓜藤秸秆、丝瓜络和香料水；搅拌并混合均匀，后加热煮沸，煮沸后持续煮沸25-35分钟得到发酵原料；
步骤五：将发酵原料打散至浆糊状，后降温；自然降温至22～24℃；用酸度计测量PH值为酸度条件pH为1.0～1.5，将降温后的发酵原料放入发酵池添加酒曲、SOD超氧化物歧化酶和酵母菌用电动搅拌器搅拌机均匀密封发酵165-175小时得酒醅。
步骤六：将发酵好的酒醅，先将蒸锅笼屉内扑一层80目棉织纱布，将酒醅倒入蒸锅笼屉内棉织纱布上，包扎好放在蒸煮锅上层串蒸2-3小时；通过蒸酒把醅中的酒精、水、高级醇、酸类等有效成分蒸发为蒸汽，再经冷却即可得到白酒。蒸馏时应尽量把酒精、芳香物质、醇甜物质等提取出来除去杂质。所得液体即为一种通络降糖护肝酒。
与现有技术相比，本发明的有益效果为：
1、本发明采用原料均为药食同源原料及新食品原料，没有毒副作用，避免对人体健康产生影响；具备抗疲劳功效。
2、本发明的制备方法不但可以保留食材独有的成分和色素，也可以保证产品的外观色泽以及原料独特的口感；显著提高了原料中有效成分的提取率；可以满足产品对外观稳定性的要求，也能尽量地不破坏功效成分，使其保留完整。
3、本发明提供的优化工艺，用多种生态植物保留了原材料的香气，绵喉纯正，香气弥人，且具有通络降糖护肝保健功效及较高的营养价值，成品呈色，口感较好，药香浓郁整体协调，风味更加突出，久置后也无沉淀物质产生。
4、能治祛风除湿，舒筋活络；用于筋骨疼痛。调节血糖，调节血脂，降血脂，对血糖具有双向调节作用，即可使糖尿病患者血糖降低，又能使低血糖病人血糖升高。可以控制尿糖，酸碱平衡，有降低血压的功效。性温和，无副作用，可长期服用。
5、酒的口感好；提高提香效率；该酒清雅、锦甜、爽洌、洄味、软畅；工艺简单，省工、省时、省力、省钱，比传统酿酒产量增产10-12％出酒率。
具体实施方式：
实施例1
一种通络降糖护肝酒，由以下重量份原料组分：鲜紫土豆48份、洋姜7份、虫草参6份、绿豆5份、藜麦4份、新鲜干丝瓜藤秸秆13份、丝瓜络4份、酒曲1份、SOD超氧化物歧化酶0.001份、酵母菌0.003份、香料水12份。
所述的香料水包括化橘红、干菊花、水；所述的添加比例为0.5：0.5：100。
一种通络降糖护肝酒的制备方法，包括以下步骤：
步骤一：将熟鲜紫土豆，洋姜、虫草参洗净，沥干水分，切成2厘米厚的片，上容器蒸20分钟；
步骤二：将颗粒饱满、无霉烂的绿豆、藜麦用清水淘洗干净，把饮用水用容器加温38度把淘洗好的绿豆，黎麦浸泡24小时后，煮锅加入60%水倒入泡好绿豆，黎麦煮15分钟绿豆煮开花，捞出备用；
步骤三：将步骤一、步骤二所得物混合后放入容器中破碎为泥状；充分搅拌混合均匀；
步骤四：将步骤三所得物质加入无霉烂、变质、干叶的破碎至2mm的新鲜干丝瓜藤秸秆、丝瓜络和香料水；搅拌并混合均匀，后加热煮沸，煮沸后持续煮沸25-35分钟得到发酵原料；
步骤五：将发酵原料打散至浆糊状，后降温；自然降温至23℃；用酸度计测量PH值为酸度条件pH为1.2，将降温后的发酵原料放入发酵池添加酒曲为SOD超氧化物歧化酶和酵母菌用电动搅拌器搅拌机均匀密封发酵170小时得酒醅。
步骤六：将发酵好的酒醅，先将蒸锅笼屉内扑一层80目棉织纱布，将酒醅倒入蒸锅笼屉内棉织纱布上，包扎好放在蒸煮锅上层串蒸2.5小时；通过蒸酒把醅中的酒精、水、高级醇、酸类等有效成分蒸发为蒸汽，再经冷却即可得到白酒。蒸馏时应尽量把酒精、芳香物质、醇甜物质等提取出来除去杂质。所得液体即为一种通络降糖护肝酒。
实施例2
一种通络降糖护肝酒，由以下重量份原料组分：鲜紫土豆50份、洋姜5份、虫草参5份、绿豆5份、藜麦5份、新鲜干丝瓜藤秸秆15份、丝瓜络2份、酒曲1份、SOD超氧化物歧化酶0.001份、酵母菌0.005份、香料水15份。
所述的香料水包括化橘红、干菊花、水；所述的添加比例为1：1： 150。
一种通络降糖护肝酒的制备方法，包括以下步骤：
步骤一：将熟鲜紫土豆，洋姜、虫草参洗净，沥干水分，切成1.8厘米厚的片，上容器蒸22分钟；
步骤二：将颗粒饱满、无霉烂的绿豆、藜麦用清水淘洗干净，把饮用水用容器加温38度把淘洗好的绿豆，黎麦浸泡23小时后，煮锅加入60%水倒入泡好绿豆，黎麦煮13分钟绿豆煮开花，捞出备用；
步骤三：将步骤一、步骤二所得物混合后放入容器中破碎为泥状；充分搅拌混合均匀；
步骤四：将步骤三所得物质加入无霉烂、变质、干叶的破碎至3mm的新鲜干丝瓜藤秸秆、丝瓜络和香料水；搅拌并混合均匀，后加热煮沸，煮沸后持续煮沸28分钟得到发酵原料；
步骤五：将发酵原料打散至浆糊状，后降温；自然降温至22；用酸度计测量PH值为酸度条件pH为1.5，将降温后的发酵原料放入发酵池添加酒曲为SOD超氧化物歧化酶和酵母菌用电动搅拌器搅拌机均匀密封发酵168小时得酒醅。
步骤六：将发酵好的酒醅，先将蒸锅笼屉内扑一层80目棉织纱布，将酒醅倒入蒸锅笼屉内棉织纱布上，包扎好放在蒸煮锅上层串蒸2-3小时；通过蒸酒把醅中的酒精、水、高级醇、酸类等有效成分蒸发为蒸汽，再经冷却即可得到白酒。蒸馏时应尽量把酒精、芳香物质、醇甜物质等提取出来除去杂质。所得液体即为一种通络降糖护肝酒。
实施例3
一种通络降糖护肝酒，由以下重量份原料组分：鲜紫土豆52份、洋姜8份、虫草参10份、绿豆3份、藜麦6份、新鲜干丝瓜藤秸秆10份、丝瓜络5份、酒曲2份、SOD超氧化物歧化酶0.0008份、酵母菌0.009份、香料水20份。
所述的香料水包括化橘红、干菊花、水；所述的添加0.8：0.7：120。
一种通络降糖护肝酒的制备方法，包括以下步骤：
步骤一：将熟鲜紫土豆，洋姜、虫草参洗净，沥干水分，切成1.9厘米厚的片，上容器蒸22分钟；
步骤二：将颗粒饱满、无霉烂的绿豆、藜麦用清水淘洗干净，把饮用水用容器加温38度把淘洗好的绿豆，黎麦浸泡25小时后，煮锅加入60%水倒入泡好绿豆，黎麦煮19分钟绿豆煮开花，捞出备用；
步骤三：将步骤一、步骤二所得物混合后放入容器中破碎为泥状；充分搅拌混合均匀；
步骤四：将步骤三所得物质加入无霉烂、变质、干叶的破碎至2mm的新鲜干丝瓜藤秸秆、丝瓜络和香料水；搅拌并混合均匀，后加热煮沸，煮沸后持续煮沸35分钟得到发酵原料；
步骤五：将发酵原料打散至浆糊状，后降温；自然降温至22℃；用酸度计测量PH值为酸度条件pH为 1.5，将降温后的发酵原料放入发酵池添加酒曲、SOD超氧化物歧化酶和酵母菌用电动搅拌器搅拌机均匀密封发酵175小时得酒醅。
步骤六：将发酵好的酒醅，先将蒸锅笼屉内扑一层80目棉织纱布，将酒醅倒入蒸锅笼屉内棉织纱布上，包扎好放在蒸煮锅上层串蒸3小时；通过蒸酒把醅中的酒精、水、高级醇、酸类等有效成分蒸发为蒸汽，再经冷却即可得到白酒。蒸馏时应尽量把酒精、芳香物质、醇甜物质等提取出来除去杂质。所得液体即为一种通络降糖护肝酒。
实施案例1
患者：佟星，年龄49岁，病症：医院诊断2 型糖尿病患者；中医辨证均为肺肾两亏型。均采用控制饮食，适当运动，常规有合并症（肥胖综合症引起的高血压，由于他的胖导致他得了高血压，原因血液会循环不畅，身体机能下降引起高血压，出现头晕头痛，疲劳，心悸的情况由于身材庞大，对血液循环的要求更高，这就导致了血液总量的增高和心脏的输出总量也增多，每分钟排入血管的血量增加，最终导致了血液增高。发病原因饮食不节：营养过甚超过了人体需要的标准，使多余部分长期滞留体内而致病。食而不净：冰川消融，工业废气污染环境，粮农、菜农、果农大量使用农药，化肥、增长素，养殖商给猪、牛、鸡、鱼大量畏食含有添加剂、激素等化学合成饲料，经消商给熟食加工制品参加一些不规范的添加剂，人们长期食用如果消毒处理不当难勉一些残留的有害物质随食品进入人体长期停滞而破坏，缺少锻炼：代谢失常，长期堆积体内五脏六腑及血液中，使人体气血流通不畅致使痰、湿生成阻塞，形成气滞血瘀的病理现象而由肥胖引起的高血压，通过减肥同时，合理的运动方式）配合调理。 服用
每天 2剂， 每次100ml共 200ml， 中午、 晚分服 ，服用时间为2个疗程（1个疗程为1个月）。 两组均观察两个疗程。治疗结果如下表显示：
| 分类 | 空腹 | 餐后2小时 |
| 服用前 | 9.3mmol/ L | 8.0mmol/ L |
| 服用后 | 6.0 mmol/ L | 7.2mmol/ L |
实施例2；
姓名：叶飞，男性，年龄52岁，2020年5月医院就诊。诊断为2型糖尿病患者。症状：自诉1年前体重下降，食多、尿频量多、时混浊如膏脂。双膝酸软乏力，头晕耳呜，多梦，性欲减退，舌质红苔黄、脉细。检查空腹血糖为18.5mmol/L，诊断为糖尿病，口服盐酸二甲双胍片半年，临床症状有所减轻，但空腹血糖仍保持在11.2mmol/L和13.6mmol/L之间。服用本产品30剂，每天2剂，每次100ml共200ml，中午、 晚分两次服，即15天后，空腹血糖为6.2mmol/L，餐后血糖为10.3mmol/L。继续饮用半年后，空腹血糖为6.0mmol/L，餐后血糖为7.6mmol/L饮用期间未发现有副作用。
实施例3
患者马高尚，男，56岁。2018年3月3日医院就诊；患者自述近2月来胸闷明显，时发心悸。服用中草药及“丹参滴丸”等药物治疗，效果不显。诊见：胸闷时轻时重，时发心悸，伴见纳食尚可，食后腹胀，胁下满闷，矢气较频，大便每日2~3行，食冷物后则易泻下，不喜饮水，手足心热，周身酸疼，双下肢浮肿，睡眠欠佳。身体偏胖，舌暗淡紫，舌苔白腻，脉沉细。既往有高血压病史、高脂血症史。经查甘油三酯6.3mmol/L，胆固醇2.1mmol/L。辨证为食积郁滞，痰浊痹阻，升降失司。服用本产品90剂服，每天2剂，，每次100ml共200ml，中午、 晚分两次服，即45天。2018年4月18日：患者自诉周身觉筋骨肌肉伸展舒畅，胸闷、心悸、腹胀、胁下满闷已无，纳食好，大便日1行，睡眠好，双下肢已无浮肿。4月25日查血生化系列，血脂5,3mmol/L。一星期后复查，血脂5.3mmol/L。5.2，甘油三酯1.7mmol/L，胆固醇2.6mmol/L。舌质淡暗，苔腻减轻，脉沉细。痰浊渐去，升降渐复，适当锻炼，生活有规律。3个月后电话随访，无明显不适，血脂正常。
实施案例4：
刘发金，男性，47岁，办公室人员劳动强度低，因“肝区胀痛6月”就诊。患者精神、食欲可。否认肝病家族史，母亲为糖尿病患者。患者饮酒25年，约150-200g/d;查体B超提示脂肪肝5年。查体：血压150/90mmHg，体重78kg，身高170cm，腰围102cm，体重指数约为27。中医查体：舌质暗，舌体胖，有齿痕，苔白腻，脉弦滑。化验检查：肝功能轻度异常（ALT:121U/L，高血压：21.9mmol/L，余基本正常），空腹血糖：6.42mmol/L，餐后小时血糖11mmol/L，TG：11.19mmol/L，胰岛素测定：23.18，彩超提示：脂肪肝（中度），抗-HCV阴性，HbsAg阴性。医院诊断：高血压：表现为头晕、头痛、头胀、眩晕、耳鸣、心慌、四肢麻木、面红、烦躁、失眠等，高血压性心脏病、动脉血管壁改变，肾脏损害心、脑、肾胸痹、中风、水肿等情志、失调、饮食不节内伤虚损有关长期饮酒，过食肥甘炙食，积湿生热，损伤脾胃，肝脾气机阻滞，酿生本病。酒精性脂肪肝性肝炎、高血压病1级、高甘油三酯血症、葡萄糖耐量异常。中医方面考虑存在肝郁脾虚。患者清淡饮食，鼓励饮水，参加轻度有氧运动。每天定量饮用中午、晚上各100克，患者控制进食的总热量，热量大的食物少吃。少吃油腻的食物，增加高纤维食品的比例。低糖，少盐，以粗粮为主。患者饮用本品30天后，血压120/80mmHg左右，体重下降2kg，腰围达到98cm，肝功能渐恢复（ALT:62U/L，TBIL:15.1umol/L），血脂（TG：2.88mmol/L），胰岛素测定：14.31，空腹血4.03mmol/L，餐后2小时血糖7.8mmol/L。服用本品2个半月时，血压稳定于120/80mmHg左右，体重再下降2.5kg，腰围达到92cm，舌质淡红，舌苔薄白，齿痕减少，脉弦。肝功能基本正常（ALT:31U/L，TBIL:15.4umol/L），血脂（TG：.71mmol/L），
实施案例5：
患者：邓士良男68岁；四个月前经常性的感觉"疲乏无力、腹胀、肝区疼痛难忍，经医院诊断，形体肥胖，肝脏肿大，腹部胀满，无压痛，反跳痛，肌紧张，查血脂：血清总胆12.3mmol/L,甘油三脂3.8mmol/L,查肝功能ALT70u/L,总胆红素40ummol/L.B超提示：肝脏增大，"特异性脂肪肝波形".最终诊断为酒精性脂肪肝，经当地治疗一段时间，效果并不理想，
随后本产品两个星期每天定量饮用中午，晚上各100克，疼痛现象明显的消失很多，也没有再腹痛的症状，对其进行检查，结果显示：腹部平软，无压痛，反跳痛。继续治疗4个星期，患者无不适症状，B超提示：肝脏轻度增大，已基本痊愈。巩固疗效2个星期，随访未见邓先生有复发的征兆。
实施例6：
患者毛志新年龄4l岁；身高170，体重缺有240多斤。症状；平时喜欢吃油腻的食物，年前查出脂肪肝比较严重，胆固醇和血脂超标，当时没当回事，2月份出现吃不下饭、疲倦乏力、恶心才想起治疗。每天中午，晚上分别饮用本产品100克，经过6个星期饮用，疼痛消失.功能恢复. 6月后基本恢复进入正常。
实施例7
姓名：陈蓝 女 52岁 症状；湿气重妇科病
内分泌紊乱，头发爱出油，排便粘稠(不易冲掉)，小肚子大，耳内湿(耳禅湿）阴部潮湿，小腿肿胀，全身肌肉酸痛、脖子僵硬和头疼、头晕。有瘀血阻络的现象；妇科炎症、更年期综合征。
每天早中晚3次，每次60毫升饮用通络降糖护肝酒经过3星期调理疗效，慢慢内风湿疼痛消失，气血通顺，女性的经络瘀阻妇科疾病功能恢复。
以上所述仅为本发明的较佳实施例，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种通络降糖护肝酒，其特征在于:由以下重量份原料组分：鲜紫土豆45-55份、洋姜3-10份、虫草参3-10份、绿豆3-10份、藜麦3-10份、新鲜干丝瓜藤秸秆10-20份、丝瓜络1-5份、酒曲0.5-2份、SOD超氧化物歧化酶0.0005-0.002份、酵母菌0.001-0.010份、香料水10-20份。
2.根据权利要求1所述一种通络降糖护肝酒组合物，其特征在于：优先的由以下重量份原料组分：鲜紫土豆50份、洋姜5份、虫草参5份、绿豆5份、藜麦5份、新鲜干丝瓜藤秸秆15份、丝瓜络2份、酒曲1份、SOD超氧化物歧化酶0.001份、酵母菌0.005份、香料水15份。
3.根据权利要求1所述的一种通络降糖护肝酒，其特征在于：所述的香料水包括化橘红、干菊花、水；所述的添加比例为0.5 -1：0.5-1：100-150。
4.一种通络降糖护肝酒的制备方法，其特征在于：包括以下步骤：
步骤一：将熟鲜紫土豆，洋姜、虫草参洗净，沥干水分，切成1.8-2.2厘米厚的片，上容器蒸18-23分钟；
步骤二：将颗粒饱满、无霉烂的绿豆、藜麦用清水淘洗干净，把饮用水用容器加温38度把淘洗好的绿豆，黎麦浸泡23-25小时后，煮锅加入60%水倒入泡好绿豆，黎麦煮10-20分钟绿豆煮开花，捞出备用；
步骤三：将步骤一、步骤二所得物混合后放入容器中破碎为泥状；充分搅拌混合均匀；
步骤四：将步骤三所得物质加入无霉烂、变质、干叶的破碎至2-3mm的新鲜干丝瓜藤秸秆、丝瓜络和香料水；搅拌并混合均匀，后加热煮沸，煮沸后持续煮沸25-35分钟得到发酵原料；
步骤五：将发酵原料打散至浆糊状，后降温；自然降温至22～24℃；用酸度计测量PH值为酸度条件pH为1.0～1.5，将降温后的发酵原料放入发酵池添加酒曲、SOD超氧化物歧化酶和酵母菌用电动搅拌器搅拌机均匀密封发酵165-175小时得酒醅；
步骤六：将发酵好的酒醅，先将蒸锅笼屉内扑一层80目棉织纱布，将酒醅倒入蒸锅笼屉内棉织纱布上，包扎好放在蒸煮锅上层串蒸2-3小时；通过蒸酒把醅中的酒精、水、高级醇、酸类等有效成分蒸发为蒸汽，再经冷却即可得到白酒；蒸馏时应尽量把酒精、芳香物质、醇甜物质等提取出来除去杂质；所得液体即为一种通络降糖护肝酒。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111058662.0A CN113621461A (zh) | 2021-09-10 | 2021-09-10 | 一种通络降糖护肝酒及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111058662.0A CN113621461A (zh) | 2021-09-10 | 2021-09-10 | 一种通络降糖护肝酒及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113621461A true CN113621461A (zh) | 2021-11-09 |
Family
ID=78389582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111058662.0A Pending CN113621461A (zh) | 2021-09-10 | 2021-09-10 | 一种通络降糖护肝酒及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113621461A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114058458A (zh) * | 2021-12-23 | 2022-02-18 | 化州市橘安食品有限公司 | 一种橘红酒及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101724533A (zh) * | 2009-12-30 | 2010-06-09 | 邹光友 | 一种紫薯酒的加工方法 |
| CN105802807A (zh) * | 2016-06-08 | 2016-07-27 | 洛阳理工学院 | 一种香味浓郁的功能性白酒及其制作方法 |
| CN107574083A (zh) * | 2017-10-29 | 2018-01-12 | 贵州布依深泉养殖专业合作社 | 一种护肝白酒及其制备方法 |
| CN108070496A (zh) * | 2018-02-27 | 2018-05-25 | 山东兰陵美酒股份有限公司 | 一种低含杂醇油的保健型红曲黍米黄酒的制备方法 |
-
2021
- 2021-09-10 CN CN202111058662.0A patent/CN113621461A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101724533A (zh) * | 2009-12-30 | 2010-06-09 | 邹光友 | 一种紫薯酒的加工方法 |
| CN105802807A (zh) * | 2016-06-08 | 2016-07-27 | 洛阳理工学院 | 一种香味浓郁的功能性白酒及其制作方法 |
| CN107574083A (zh) * | 2017-10-29 | 2018-01-12 | 贵州布依深泉养殖专业合作社 | 一种护肝白酒及其制备方法 |
| CN108070496A (zh) * | 2018-02-27 | 2018-05-25 | 山东兰陵美酒股份有限公司 | 一种低含杂醇油的保健型红曲黍米黄酒的制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114058458A (zh) * | 2021-12-23 | 2022-02-18 | 化州市橘安食品有限公司 | 一种橘红酒及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103211162A (zh) | 一种经发酵处理的杂粮食品及其制备方法 | |
| CN104531477A (zh) | 一种牡丹养肾酒及其制备方法 | |
| CN103211257B (zh) | 一种降血糖苹果醋保健饮料及其制备方法 | |
| CN107897604A (zh) | 一种缓解体力疲劳的西洋参饮品制备方法 | |
| CN105851740A (zh) | 一种健胃消食保健饮料及其制备方法 | |
| CN106962904A (zh) | 辟谷丹及其制备方法 | |
| CN113621461A (zh) | 一种通络降糖护肝酒及其制备方法 | |
| CN108837121A (zh) | 一种治疗高尿酸的中药组合物及其制备方法 | |
| CN112755138A (zh) | 一种益气健脾棒棒糖及其制备方法 | |
| CN105623995B (zh) | 山里红开胃酒及饮料及其制备方法 | |
| CN106544215A (zh) | 一种客家黄酒的制作方法 | |
| CN106560047A (zh) | 一种挤压成型苦荞茶的制备工艺 | |
| CN106071681A (zh) | 一种苦荞粉的加工方法 | |
| CN105695236A (zh) | 一种养生保健酒的配方及生产工艺 | |
| CN107372717A (zh) | 一种具有美容减肥功效的曲奇饼干及其制备方法 | |
| CN108456604A (zh) | 一种养生保健苦荞酒 | |
| CN1262637C (zh) | 一种元气补酒的配方及其制备方法 | |
| CN107372947B (zh) | 一种泡袋式降糖茶及其制备方法 | |
| CN111264644A (zh) | 一种人参黑茶及其制备方法 | |
| CN104814372A (zh) | 一种基于甘薯的保健龟苓膏及其制备方法 | |
| CN104605268A (zh) | 具有治疗糖尿病患功效的猪肚粥及制备方法 | |
| CN104606571A (zh) | 一种生津止渴鲜菠菜根代茶饮及制备方法 | |
| CN104255922A (zh) | 适宜三高人群饮用的保健牛奶及其制备方法 | |
| CN102871082A (zh) | 具有改善睡眠和润肠通便功能的短梗五加菜及其制备方法 | |
| CN106071683A (zh) | 苦荞米的加工方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 017000 shop 11, building 18, riyuexuan community, east of Linyin South Road, Xini Town, Hangjin Banner, Ordos City, Inner Mongolia Autonomous Region Applicant after: Inner Mongolia Zhonghuayuan Economic Development Co.,Ltd. Address before: 017000 shop 11, building 18, riyuexuan community, east of Linyin South Road, Xini Town, Hangjin Banner, Ordos City, Inner Mongolia Autonomous Region Applicant before: Inner Mongolia Jintian yemudan Biotechnology Development Co.,Ltd. |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211109 |